News | December 06, 2022
JB Pharma reduces price of Azmarda by 50%
Move to increase affordability and accessibility for heart failure patients across the country
Move to increase affordability and accessibility for heart failure patients across the country
The service includes full fertility care benefits, including egg and embryo freezing options to employees
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
It offers quick relief in various types of Coughs, Colds and Sore Throat,
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Evaluating Investigational Sitravatinib in combination with Nivolumab for patients with non-squamous non-small cell lung cancer
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
Subscribe To Our Newsletter & Stay Updated
